Gene Expression Omnibus (GEO) dataset analysis demonstrated that the elevated ALKBH5 expression was correlated with myeloma disease progression from normal to smoldering myeloma (SMM) (Fig. 1C) [29] and from MM to plasma cell leukemia (PCL) (Fig. 1D) [30]. This evidence concerns the gene ALKBH5 and plasma cell leukemia.